Versant Capital Management, Inc 10x Genomics, Inc. Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 282 shares of TXG stock, worth $4,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
282
Previous 1,605
82.43%
Holding current value
$4,018
Previous $36,000
88.89%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
293Shares Held
98.2MCall Options Held
263KPut Options Held
85.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$170 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$156 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.48MShares$92.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$91.1 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$90.8 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.35B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...